Mutation characteristics in type I collagen genes in Chinese patients with osteogenesis imperfecta

被引:6
作者
Yang, Z. [1 ]
Ke, Z. F. [1 ]
Zeng, C. [1 ]
Wang, Z. [1 ]
Shi, H. J. [1 ]
Wang, L. T. [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteogenesis imperfecta; COL1A1; COL1A2; Heredity; Mutation; CARBOXYL-TERMINAL PROPEPTIDE; BONE; CARTILAGE; DISEASES; PROTEIN; INTRON; CHAIN;
D O I
10.4238/vol10-1gmr984
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteogenesis imperfecta is normally caused by an autosomal dominant mutation in the type I collagen genes COL1A1 and COL1A2. The severity of osteogenesis imperfecta varies, ranging from perinatal lethality to a very mild phenotype. Although there have been many reports of COL1A1 and COL1A2 mutations, few cases have been reported in Chinese people. We report on five unrelated families and three sporadic cases. The mutations were detected by PCR and direct sequencing. Four mutations in COL1A1 and one in COL1A2 were found, among which three mutations were previously unreported. The mutation rates of G > C at base 128 in intron 31 of the COL1A1 gene and G > A at base 162 in intron 30 of the COL1A2 gene were higher than normal. The patients' clinical characteristics with the same mutation were variable even in the same family. We conclude that mutations in COL1A1 and COL1A2 also have an important role in osteogenesis imperfecta in the Chinese population. As the Han Chinese people account for a quarter of the world's population, these new data contribute to the type I collagen mutation map.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 21 条
[1]   Brief report: Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta [J].
Barnes, Aileen M. ;
Cliang, Weizhong ;
Morello, Roy ;
Cabral, Wayne A. ;
Weis, MaryAnn ;
Eyre, David R. ;
Leikin, Sergey ;
Makareeva, Elena ;
Kuznetsova, Natalia ;
Uveges, Thomas E. ;
Ashok, Aarthi ;
Flor, Armando W. ;
Mulvihill, John J. ;
Wilson, Patrick L. ;
Sundaram, Usha T. ;
Lee, Brendan ;
Marini, Joan C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26) :2757-2764
[2]  
Benusiené E, 2003, J APPL GENET, V44, P95
[3]   Transcriptional regulatory sequences within the first intron of the chicken apolipoproteinAI (apoAI) gene [J].
Bhattacharyya, N ;
Banerjee, D .
GENE, 1999, 234 (02) :371-380
[4]  
CHESSLER SD, 1993, J BIOL CHEM, V268, P18218
[5]   Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB [J].
Clement, JQ ;
Wilkinson, MF .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 299 (05) :1179-1191
[6]   Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen [J].
Di Lullo, GA ;
Sweeney, SM ;
Körkkö, J ;
Ala-Kokko, L ;
San Antonio, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) :4223-4231
[7]  
ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.bb.20.060191.001033
[8]   Osteogenesis imperfecta: Prospects for molecular therapeutics [J].
Forlino, A ;
Marini, JC .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :225-232
[9]   Type V osteogenesis imperfecta: A new form of brittle bone disease [J].
Glorieux, FH ;
Rauch, F ;
Plotkin, H ;
Ward, L ;
Travers, R ;
Roughley, P ;
Lalic, L ;
Glorieux, DF ;
Fassier, F ;
Bishop, NJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (09) :1650-1658
[10]   Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients [J].
Hartikka, H ;
Kuurila, K ;
Körkkö, J ;
Kaitila, L ;
Grénman, R ;
Pynnönen, S ;
Hyland, JC ;
Ala-Kokko, L .
HUMAN MUTATION, 2004, 24 (02) :147-154